"Joe Rogan was right," says the former anchor for CNN, where he once said its proponents "need to be called out and shamed" ...

A team of Polish researchers from four universities has made a significant discovery regarding long COVID, the potentially ...

AstraZeneca has started to pull its Covid-19 vaccine from global markets because of low demand, the pharmaceutical giant said ...

Those who are more vulnerable to getting sick during a spring or summer surge may benefit from the new monoclonal antibody Pemgarda, a new treatment that was granted emergency use by the FDA in March, ...

As Americans strive to move beyond Covid-19, it is important to acknowledge that for their 7 million immunocompromised fellow ...

NV-387 Possesses Strong Orthopoxvirus Activity Relevant to Both Sexual and Inhalation Modes of Transmission, Says NanoViricides ...

Researchers have developed a novel vaccination approach using Quartet nanocages that display receptor-binding domains (RBDs) from different sarbecoviruses, showing enhanced immune responses and ...

They evaluated longitudinal specimens collected during hospitalization from a subset of 642 patients with COVID-19 ... 2 RNA and antigen measured during treatment were associated with improved patient ...

In the realm of pediatric healthcare, managing infectious diseases represents a pivotal challenge, given the distinctive physiological responses and developmental considerations unique to children.

The FDA-approved antiviral Paxlovid is underused for high-risk COVID-19 patients, despite its efficacy in preventing severe illness.

Researchers identified a potential treatment for long COVID by restoring the function of ion channels in immune cells using low-dose Naltrexone.

“COVID-19 remains ... molecule therapies for the treatment of respiratory viral diseases and cancer. The viral respiratory disease program includes an oral inhibitor of the SARS-CoV-2 Mpro (3CL ...